Total Hip Arthroplasty
Conditions
Keywords
total hip arthroplasty, peng block, Hip, Anatomy, Sciatic nerve block
Brief summary
This study aims to evaluate the effectiveness of a posterior hip capsule block performed in addition to a PENG (Pericapsular Nerve Group) block for patients undergoing hip arthroplasty. The primary objective is to assess whether this combined approach provides enhanced perioperative analgesia compared to the standard analgesic protocol or the PENG block alone. Secondary outcomes will focus on opioid consumption, functional recovery, and any potential complications. By targeting both the anterior and posterior innervation pathways around the hip joint, this combined technique could improve patient comfort, decrease opioid requirements, and potentially expedite rehabilitation after hip arthroplasty.
Interventions
PROCEDUREDeep posterior post gluteal nerve block
One injection with ultrasound guidance injection of 5, 10 or 15 mL of naropeine 0.35 % Procedure : injection below the piriformis muscle in front of the head of the femur.
Sponsors
Quincy Anesthésie
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
All adults with total hip arthroplasty \-
Exclusion criteria
* Contraindication to regional anesthesia * allergy * refusal of the injection
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Sciatic nerve block | From enrollment to the end of treatment at 1 month | number of patients with postoperative sciatic motor or sensitory nerve block collected by clinical examination (test with hot and cold in the sciatic territory and motricity of the feet) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Pain postoperative | From enrollment to the end of treatment at 1 MONTH | Visual analogic pain (VAS) AT 6 hours 0 : no pain 10: maximum pain |
| pain 2 | From enrollment to the end of treatment at 1 MONTH | Visual analogic pain (VAS) AT 12 hours 0 : no pain 10: maximum pain |
| RAAC | From enrollment to the end of treatment at 1 MONTH | QOR15 scale at H24 and H48 questionnaire with 15 questions from 0 to 10 (https://pqip.org.uk/FilesUploaded/Myles%20QoR-15.pdf) |
| oPIOID Consumption | From enrollment to the end of treatment at 7 months | Opioid consumption per and postoperative until 48 hours |
| Surgical complication | From enrollment to the end of treatment at 1 MONTH | Surgical postoperative complication or fall |
Contacts
Primary ContactYOANN ELMALEH, M.D
Outcome results
None listed